Dr Levy on the Evolution of ADCs in NSCLC

Benjamin Philip Levy, MD, discusses the evolution of antibody-drug conjugates in non-small cell lung cancer following updated data to be read out for this treatment population throughout 2023.

Related Keywords

,Johns Hopkins University School Of Medicine ,Johns Hopkins Sidney Kimmel Cancer Center ,Benjamin Philip Levy ,Johns Hopkins University School ,Medical Oncology ,Sibley Memorial Hospital ,Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins ,Onclive Tv ,Lung Cancer ,